Soluble guanylate cyclase stimulators in patients with heart failure with reduced ejection fraction across the risk spectrum.

Butler J, Usman MS, Anstrom KJ, Blaustein RO, Bonaca MP, Ezekowitz JA, Freitas C, Lam CSP, Lewis EF, Lindenfeld J, McMullan CJ, Mentz RJ, O'Connor C, Rosano GMC, Saldarriaga CI, Senni M, Udelson J, Voors AA, Zannad F

Open source

DOI: 10.1002/ejhf.2720
Published: 2022 Nov
Container: European journal of heart failure
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/ejhf.2720,
  title = {Soluble guanylate cyclase stimulators in patients with heart failure with reduced ejection fraction across the risk spectrum.},
  author = {Butler J and Usman MS and Anstrom KJ and Blaustein RO and Bonaca MP and Ezekowitz JA and Freitas C and Lam CSP and Lewis EF and Lindenfeld J and McMullan CJ and Mentz RJ and O'Connor C and Rosano GMC and Saldarriaga CI and Senni M and Udelson J and Voors AA and Zannad F},
  year = {2022},
  journal = {European journal of heart failure},
  doi = {10.1002/ejhf.2720},
  url = {https://doi.org/10.1002/ejhf.2720}
}

RIS

TY  - JOUR
TI  - Soluble guanylate cyclase stimulators in patients with heart failure with reduced ejection fraction across the risk spectrum.
AU  - Butler J
AU  - Usman MS
AU  - Anstrom KJ
AU  - Blaustein RO
AU  - Bonaca MP
AU  - Ezekowitz JA
AU  - Freitas C
AU  - Lam CSP
AU  - Lewis EF
AU  - Lindenfeld J
AU  - McMullan CJ
AU  - Mentz RJ
AU  - O'Connor C
AU  - Rosano GMC
AU  - Saldarriaga CI
AU  - Senni M
AU  - Udelson J
AU  - Voors AA
AU  - Zannad F
PY  - 2022
JO  - European journal of heart failure
DO  - 10.1002/ejhf.2720
UR  - https://doi.org/10.1002/ejhf.2720
ER  -

APA

J, B., MS, U., KJ, A., RO, B., MP, B., JA, E., C, F., CSP, L., EF, L., J, L., CJ, M., RJ, M., C, O., GMC, R., CI, S., M, S., J, U., AA, V., & F, Z. (2022). Soluble guanylate cyclase stimulators in patients with heart failure with reduced ejection fraction across the risk spectrum.. European journal of heart failure. https://doi.org/10.1002/ejhf.2720

Source records

pubmed · retrieved 2026-09-25T15:26:39.900Z